Stereotaxis (STXS) Cash & Equivalents (2010 - 2026)

Stereotaxis (STXS) has 17 years of Cash & Equivalents data on file, last reported at $14.6 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $14.6 million, up 37.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.6 million (up 37.87% YoY), and the FY2025 annual result was $13.4 million, up 9.86% from the prior year.
• Cash & Equivalents climbed to $14.6 million in Q1 2026 per STXS's latest filing, from $13.4 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $35.1 million in Q2 2022 and troughed at $6.8 million in Q1 2023.
• A 5-year average of $17.4 million and a median of $14.6 million in 2026 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 80.74% in 2023, then soared 169.91% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $8.6 million in 2022, then jumped by 130.82% to $19.8 million in 2023, then plunged by 38.35% to $12.2 million in 2024, then grew by 9.86% to $13.4 million in 2025, then increased by 8.9% to $14.6 million in 2026.
• Business Quant data shows STXS's Cash & Equivalents at $14.6 million in Q1 2026, $13.4 million in Q4 2025, and $10.5 million in Q3 2025.